Showing results (11-20 of 3,804) with videos related to
Sort By:
Pageof 381
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|December 22, 2016
[Research progress of circulating tumor cells: the way from counting to subtyping]J B Li, Z F JiangZhonghua Yi Xue Za Zhi|May 28, 2026
[Key points and interpretation of Chinese expert's consensus on endocrine therapy of breast cancer (2026 edition)]S H Zhang, Z F JiangZhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|February 6, 2018
[Ten hot issues of breast cancer in diagnosis and therapy in 2018]Z F Jiang, J B LiZhonghua Yi Xue Za Zhi|August 21, 2017
[A study on the correlation between Neo-Bioscoresystem and disease-free survival of breast cancer patients with neoadjuvant chemotherapy]G C Wang, F R Xu, J B Li, et al.Human & Experimental Toxicology|June 5, 2020
MicroRNA: Potential biomarker and target of therapy in acute lung injuryZ-F Jiang, L Zhang, J ShenZhonghua Yi Xue Za Zhi|May 5, 2024
[Efficacy analysis of chemotherapy and endocrine therapy combined with targeted drugs after progression on cyclin-dependent kinase 4/6 inhibitor treatment in hormone receptor positive/human epidermal growth factor receptor 2-low metastatic breast cancer]B Liu, Y Yuan, F Li, et al.Shi Yan Sheng Wu Xue Bao|June 1, 1997
[Nuclear reconstitution around purified E. coli DNA in cell-free extracts of Xenopus laevis eggs]Z F Jiang, J Qu, Z H ZhaiZhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|January 31, 2023
[Development in the last 20 years of anti-HER2 targeted therapy for breast cancer]B Liu, J B Li, Z F JiangLife Sciences|December 17, 2017
Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancerZ F Jiang, M Wang, J L XuZhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|October 28, 2020
[Expert consensus on the management of adverse events of ErbB family tyrosine kinase inhibitors in breast cancer]B Y Wang, R Ge, Z F Jiang, et al.Pageof 381